Western blot analysis consistently showed that PRMT5 knockdown suppressed PMS2 expression, whereas PRMT5 overexpression upregulated PMS2 expression in CPT‐11‐treated CRC cells (Figure 4E,F). The gene discussed is PMS2; the disease is colorectal carcinoma.